Recent advances in the interpretation of the molecular mechanism of LRG1 in tumor indicated that long noncoding RNA taurine upregulated one mediated endothelial angiogenesis through the LRG1/TGF-β pathway (Fan et al., 2019), which could predict clinical outcomes after transarterial chemoembolization (Peng et al., 2020). This evidence concerns the gene TGFB1 and neoplasm.